Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 73

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Conservation of DNA-binding specificity and oligomerisation properties within the p53 family

Brandt, Tobias, Petrovich, Miriana, Joerger, Andreas C, Veprintsev, Dmitry B·2009·BMC Genomics
DOI 10.1186/1471-2164-10-628
Open this paper in CoChat — free account

Abstract

Background: Transcription factors activate their target genes by binding to specific response elements. Many transcription factor families evolved from a common ancestor by gene duplication and subsequent divergent evolution. Members of the p53 family, which play key roles in cell-cycle control and development, share conserved DNA binding and oligomerisation domains but exhibit distinct functions. In this study, the molecular basis of the functional divergence of related transcription factors was investigated. Results: We characterised the DNA-binding specificity and oligomerisation properties of human p53, p63 and p73, as well as p53 from other organisms using novel biophysical approaches. All p53 family members bound DNA cooperatively as tetramers with high affinity. Despite structural differences in the oligomerisation domain, the dissociation constants of the tetramers was in the low nanomolar range for all family members, indicating that the strength of tetramerisation was evolutionarily conserved. However, small differences in the oligomerisation properties were observed, which may play a regulatory role. Intriguingly, the DNA-binding specificity of p53 family members was highly conserved even for evolutionarily distant species. Additionally, DNA recognition was only weakly affected by CpG methylation. Prediction of p53/p63/p73 binding sites in the genome showed almost complete overlap between the different homologs. Conclusion: Diversity of biological function of p53 family members is not reflected in differences in sequence-specific DNA binding. Hence, additional specificity factors must exist, which allowed the acquisition of novel functions during evolution while preserving original roles.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2164-10-628

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 49

  1. Wilson D, Charoensawan V, Kummerfeld SK, Teichmann SA: DBD--taxonomically broad transcription factor predictions: new content and functionality. Nucleic Acids Res. 2008, D88-92. 36 Database · DOI · Paper page
  2. Amoutzias GD, Veron AS, Weiner J, Robinson-Rechavi M, Brnberg-Bauer E, Oliver SG, Robertson DL: One billion years of bZIP transcription factor evolution: conservation and change in dimerization and DNA-binding site specificity. Molecular biology and evolution. 2007, 24 (3): 827-835. 10.1093/molbev/msl211. · DOI
  3. Massari ME, Murre C: Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol. 2000, 20 (2): 429-440. 10.1128/MCB.20.2.429-440.2000. · DOI · Paper page
  4. Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature. 2000, 408 (6810): 307-310. 10.1038/35042675. · DOI · Paper page
  5. Vousden KH, Lu X: Live or let die: the cell's response to p53. Nat Rev Cancer. 2002, 2 (8): 594-604. 10.1038/nrc864. · DOI · Paper page
  6. Joerger AC, Fersht AR: Structure-function-rescue: the diverse nature of common p53 cancer mutants. Oncogene. 2007, 26 (15): 2226-2242. 10.1038/sj.onc.1210291. · DOI · Paper page
  7. Moll UM, Slade N: p63 and p73: roles in development and tumor formation. Mol Cancer Res. 2004, 2 (7): 371-386. · DOI · Paper page
  8. Jegga AG, Inga A, Menendez D, Aronow BJ, Resnick MA: Functional evolution of the p53 regulatory network through its target response elements. Proc Natl Acad Sci USA. 2008, 105 (3): 944-949. 10.1073/pnas.0704694105. · DOI · Paper page
  9. Joerger AC, Fersht AR: Structural biology of the tumor suppressor p53. Annual review of biochemistry. 2008, 77: 557-582. 10.1146/annurev.biochem.77.060806.091238. · DOI · Paper page
  10. Scoumanne A, Harms KL, Chen X: Structural basis for gene activation by p53 family members. Cancer Biol Ther. 2005, 4 (11): 1178-1185. · doi:10.4161/cbt.4.11.2254
  11. Funk WD, Pak DT, Karas RH, Wright WE, Shay JW: A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol. 1992, 12 (6): 2866-2871. · DOI · Paper page
  12. Tomso DJ, Inga A, Menendez D, Pittman GS, Campbell MR, Storici F, Bell DA, Resnick MA: Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation. Proc Natl Acad Sci USA. 2005, 102 (18): 6431-6436. 10.1073/pnas.0501721102. · DOI
  13. Veprintsev DB, Fersht AR: Algorithm for prediction of tumour suppressor p53 affinity for binding sites in DNA. Nucleic Acids Res. 2008, 36 (5): 1589-1598. 10.1093/nar/gkm1040. · DOI
  14. Schavolt KL, Pietenpol JA: p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell arrest DNA repair and apoptosis. Oncogene. 2007, 26 (42): 6125-6132. 10.1038/sj.onc.1210441. · DOI
  15. Osada M, Park HL, Nagakawa Y, Yamashita K, Fomenkov A, Kim MS, Wu G, Nomoto S, Trink B, Sidransky D: Differential recognition of response elements determines target gene specificity for p53 and p63. Mol Cell Biol. 2005, 25 (14): 6077-6089. 10.1128/MCB.25.14.6077-6089.2005. · DOI
  16. Lokshin M, Li Y, Gaiddon C, Prives C: p53 and p73 display common and distinct requirements for sequence specific binding to DNA. Nucleic Acids Res. 2007, 35 (1): 340-352. 10.1093/nar/gkl1047. · DOI
  17. Murray-Zmijewski F, Lane DP, Bourdon JC: p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ. 2006, 13 (6): 962-972. 10.1038/sj.cdd.4401914. · DOI · Paper page
  18. Petrovich M, Veprintsev DB: Effects of CpG methylation on recognition of DNA by the tumour suppressor p53. J Mol Biol. 2009, 386 (1): 72-80. 10.1016/j.jmb.2008.11.054. · DOI
  19. Weinberg RL, Veprintsev DB, Fersht AR: Cooperative binding of tetrameric p53 to DNA. J Mol Biol. 2004, 341 (5): 1145-1159. 10.1016/j.jmb.2004.06.071. · DOI · Paper page
  20. MacGregor IK, Anderson AL, Laue TM: Fluorescence detection for the XLI analytical ultracentrifuge. Biophys Chem. 2004, 108 (1-3): 165-185. 10.1016/j.bpc.2003.10.018. · DOI
  21. Adams SR, Campbell RE, Gross LA, Martin BR, Walkup GK, Yao Y, Llopis J, Tsien RY: New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications. J Am Chem Soc. 2002, 124 (21): 6063-6076. 10.1021/ja017687n. · DOI · Paper page
  22. Joerger AC, Rajagopalan S, Natan E, Veprintsev DB, Robinson CV, Fersht AR: Structural evolution of p53, p63, and p73: implication for heterotetramer formation. Proc Natl Acad Sci USA. 2009, 106 (42): 17705-17710. 10.1073/pnas.0905867106. · DOI
  23. Schneider TD, Stephens RM: Sequence logos: a new way to display consensus sequences. Nucleic Acids Res. 1990, 18 (20): 6097-6100. 10.1093/nar/18.20.6097. · DOI · Paper page
  24. Schneider TD, Stormo GD, Gold L, Ehrenfeucht A: Information content of binding sites on nucleotide sequences. J Mol Biol. 1986, 188 (3): 415-431. 10.1016/0022-2836(86)90165-8. · DOI · Paper page
  25. Bird AP, Wolffe AP: Methylation-induced repression--belts, braces, and chromatin. Cell. 1999, 99 (5): 451-454. 10.1016/S0092-8674(00)81532-9. · DOI · Paper page
  26. Jaenisch R, Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003, 33: 245-254. 10.1038/ng1089. · DOI · Paper page
  27. Watt F, Molloy PL: Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev. 1988, 2 (9): 1136-1143. 10.1101/gad.2.9.1136. · DOI · Paper page
  28. Ou HD, Lohr F, Vogel V, Mantele W, Dotsch V: Structural evolution of C-terminal domains in the p53 family. EMBO J. 2007, 26 (14): 3463-3473. 10.1038/sj.emboj.7601764. · DOI
  29. Jeffrey PD, Gorina S, Pavletich NP: Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science. 1995, 267 (5203): 1498-1502. 10.1126/science.7878469. · DOI · Paper page
  30. Clore GM, Ernst J, Clubb R, Omichinski JG, Kennedy WM, Sakaguchi K, Appella E, Gronenborn AM: Refined solution structure of the oligomerization domain of the tumour suppressor p53. Nat Struct Biol. 1995, 2 (4): 321-333. 10.1038/nsb0495-321. · DOI
  31. Lee W, Harvey TS, Yin Y, Yau P, Litchfield D, Arrowsmith CH: Solution structure of the tetrameric minimum transforming domain of p53. Nat Struct Biol. 1994, 1 (12): 877-890. 10.1038/nsb1294-877. · DOI · Paper page
  32. Coutandin D, Lohr F, Niesen FH, Ikeya T, Weber TA, Schafer B, Zielonka EM, Bullock AN, Yang A, Guntert P, Knapp S, McKeon F, Ou HD, Dotsch V: Conformational stability and activity of p73 require a second helix in the tetramerization domain. Cell Death Differ. 2009, 16 (12): 1582-1589. 10.1038/cdd.2009.139. · DOI
  33. DiGiammarino EL, Lee AS, Cadwell C, Zhang W, Bothner B, Ribeiro RC, Zambetti G, Kriwacki RW: A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nat Struct Biol. 2002, 9 (1): 12-16. 10.1038/nsb730. · DOI · Paper page
  34. Achatz MI, Olivier M, Le Calvez F, Martel-Planche G, Lopes A, Rossi BM, Ashton-Prolla P, Giugliani R, Palmero EI, Vargas FR, Da Rocha JC, Vettore AL, Hainaut P: The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Cancer Lett. 2007, 245 (1-2): 96-102. 10.1016/j.canlet.2005.12.039. · DOI · Paper page
  35. Fernandez-Fernandez MR, Veprintsev DB, Fersht AR: Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc Natl Acad Sci USA. 2005, 102 (13): 4735-4740. 10.1073/pnas.0501459102. · DOI · Paper page
  36. van Dieck J, Fernandez-Fernandez MR, Veprintsev DB, Fersht AR: Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers. J Biol Chem. 2009, 284 (20): 13804-13811. 10.1074/jbc.M901351200. · DOI
  37. Kitayner M, Rozenberg H, Kessler N, Rabinovich D, Shaulov L, Haran TE, Shakked Z: Structural basis of DNA recognition by p53 tetramers. Mol Cell. 2006, 22 (6): 741-753. 10.1016/j.molcel.2006.05.015. · DOI · Paper page
  38. Jin S, Martinek S, Joo WS, Wortman JR, Mirkovic N, Sali A, Yandell MD, Pavletich NP, Young MW, Levine AJ: Identification and characterization of a p53 homologue in Drosophila melanogaster. Proc Natl Acad Sci USA. 2000, 97 (13): 7301-7306. 10.1073/pnas.97.13.7301. · DOI · Paper page
  39. Joerger AC, Ang HC, Veprintsev DB, Blair CM, Fersht AR: Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations. J Biol Chem. 2005, 280 (16): 16030-16037. 10.1074/jbc.M500179200. · DOI · Paper page
  40. Smeenk L, van Heeringen SJ, Koeppel M, van Driel MA, Bartels SJ, Akkers RC, Denissov S, Stunnenberg HG, Lohrum M: Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res. 2008, 36 (11): 3639-3654. 10.1093/nar/gkn232. · DOI · Paper page
  41. Yang A, Zhu Z, Kapranov P, McKeon F, Church GM, Gingeras TR, Struhl K: Relationships between p63 Binding, DNA Sequence Transcription Activity and Biological Function in Human Cells. Mol Cell. 2006, 24 (4): 593-602. 10.1016/j.molcel.2006.10.018. · DOI · Paper page
  42. Noureddine MA, Menendez D, Campbell MR, Bandele OJ, Horvath MM, Wang X, Pittman GS, Chorley BN, Resnick MA, Bell DA: Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts. PLoS genetics. 2009, 5 (5): e1000462-10.1371/journal.pgen.1000462. · DOI
  43. Okorokov AL, Orlova EV: Structural biology of the p53 tumour suppressor. Curr Opin Struct Biol. 2009, 19 (2): 197-202. 10.1016/j.sbi.2009.02.003. · DOI
  44. Joerger AC, Allen MD, Fersht AR: Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations. J Biol Chem. 2004, 279 (2): 1291-1296. 10.1074/jbc.M309732200. · DOI · Paper page
  45. Nikolova PV, Henckel J, Lane DP, Fersht AR: Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability. Proc Natl Acad Sci USA. 1998, 95 (25): 14675-14680. 10.1073/pnas.95.25.14675. · DOI · Paper page
  46. Hipps DS, Packman LC, Allen MD, Fuller C, Sakaguchi K, Appella E, Perham RN: The peripheral subunit-binding domain of the dihydrolipoyl acetyltransferase component of the pyruvate dehydrogenase complex of Bacillus stearothermophilus: preparation and characterization of its binding to the dihydrolipoyl dehydrogenase component. Biochem J. 1994, 297 (Pt 1): 137-143. · doi:10.1042/bj2970137
  47. Schuck P, Perugini MA, Gonzales NR, Howlett GJ, Schubert D: Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems. Biophys J. 2002, 82 (2): 1096-1111. 10.1016/S0006-3495(02)75469-6. · DOI · Paper page
  48. Rajagopalan S, Jaulent AM, Wells M, Veprintsev DB, Fersht AR: 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers. Nucleic Acids Res. 2008, 36 (18): 5983-5991. 10.1093/nar/gkn598. · DOI
  49. Jeffrey PD, Gorina S, Pavletich NP: Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science. 1995, 267 (5203): 1498-1502. 10.1126/science.7878469. · DOI · Paper page

Cited by

See all 73

Metadata

Authors
Brandt, T., Petrovich, M., Joerger, A. C., & Veprintsev, D. B.
Venue
BMC Genomics
Publisher
Springer Science and Business Media LLC
Published
2009-12
Volume
10
Issue
1
ISSN
1471-2164
DOI
10.1186/1471-2164-10-628
Cited by
73
References
8
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Conservation of DNA-binding specificity and oligomerisation properties within the p53 family. https://app.cochat.ai/papers/10.1186/1471-2164-10-628
The paper
Brandt, T., Petrovich, M., Joerger, A. C., & Veprintsev, D. B. (2009). Conservation of DNA-binding specificity and oligomerisation properties within the p53 family. BMC Genomics. https://doi.org/10.1186/1471-2164-10-628

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.